We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
0
0 active
Approvals
Total approvals
Agencies
Regulatory bodies
Founded
N/A
No trial phase data available
No trial data available
No approval data available
- Ethris GmbH and the German Center for Infection Research (DZIF) announced a strategic collaboration to develop mRNA-based vaccines for prevention and treatment of infectious diseases. - The partnership combines Ethris' proprietary SNIM®RNA and SNaP LNP® technology platforms with DZIF's translational vaccine research expertise across viruses, bacteria, and parasites. - The collaboration aims to create next-generation mRNA vaccines with enhanced stability, targeted delivery, and variant-ready protection beyond individual respiratory viruses. - Manufacturing support will be provided by Ethris' partners Patheon and Evonik to enable both preclinical and clinical development of advanced vaccine candidates.
